Astria Therapeutics Inc. (ATXS) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-12
4:17 pm
Purchase
2024-02-0113GAstria Therapeutics, Inc.
ATXS
RA Capital Management, L.P.4,413,150
8.100%
4,413,150increase
(New Position)
Filing
History
2024-02-09
08:35 am
Purchase
2024-02-0813GAstria Therapeutics, Inc.
ATXS
FMR LLC5,444,428
14.999%
2,092,124increase
(+62.41%)
Filing
History
2024-02-05
4:14 pm
Purchase
2024-02-0113DAstria Therapeutics, Inc.
ATXS
Perceptive Advisors LLC6,485,420
11.900%
2,857,727increase
(+78.78%)
Filing
History
2024-01-29
5:26 pm
Purchase
2023-12-3113GAstria Therapeutics, Inc.
ATXS
BlackRock Inc.
BLK
2,184,558
6.000%
2,131,485increase
(+4016.14%)
Filing
History
2024-01-16
4:18 pm
Purchase
2024-01-0513GAstria Therapeutics, Inc.
ATXS
TCG Crossover GP II, LLC4,368,928
9.900%
4,368,928increase
(New Position)
Filing
History
2024-01-02
4:16 pm
Purchase
2023-12-2113GAstria Therapeutics, Inc.
ATXS
Venrock Healthcare Capital Partners III, L.P.3,225,806
8.900%
3,225,806increase
(New Position)
Filing
History
2023-10-18
4:11 pm
Purchase
2023-10-1613DAstria Therapeutics, Inc.
ATXS
Perceptive Advisors LLC3,627,693
9.900%
1,139,891increase
(+45.82%)
Filing
History
2023-02-14
3:59 pm
Unchanged
2022-12-3113GAstria Therapeutics, Inc.
ATXS
Altium Capital Management LLC1,355,372
4.950%
0
(Unchanged)
Filing
History
2023-02-14
3:45 pm
Purchase
2022-12-3113GAstria Therapeutics, Inc.
ATXS
Fairmount Funds Management LLC1,901,397
6.900%
989,661increase
(+108.55%)
Filing
History
2023-02-14
3:03 pm
Purchase
2022-12-3113GAstria Therapeutics, Inc.
ATXS
Cormorant Asset Management, LP1,650,000
6.300%
450,000increase
(+37.50%)
Filing
History
2023-02-14
08:27 am
Unchanged
2022-12-3113GAstria Therapeutics, Inc.
ATXS
Deep Track Capital, LP1,816,531
6.610%
0
(Unchanged)
Filing
History
2023-02-13
5:40 pm
Purchase
2022-12-3113GAstria Therapeutics, Inc.
ATXS
Vivo Opportunity LLC1,681,199
6.800%
681,199increase
(+68.12%)
Filing
History
2023-01-10
12:48 pm
Purchase
2023-01-0913GAstria Therapeutics, Inc.
ATXS
FMR LLC3,352,304
12.798%
3,352,304increase
(New Position)
Filing
History
2022-12-22
4:02 pm
Purchase
2022-12-1513GAstria Therapeutics, Inc.
ATXS
Deep Track Capital, LP1,816,531
7.320%
1,816,531increase
(New Position)
Filing
History
2022-12-21
4:30 pm
Purchase
2022-12-1913DAstria Therapeutics, Inc.
ATXS
Perceptive Advisors LLC2,487,802
9.900%
2,487,802increase
(New Position)
Filing
History
2022-12-21
2:12 pm
Purchase
2022-12-1513GAstria Therapeutics, Inc.
ATXS
Altium Capital Management LLC1,355,372
5.200%
1,355,372increase
(New Position)
Filing
History
2022-11-14
4:43 pm
Sale
2022-11-1413GAstria Therapeutics, Inc.
ATXS
RA Capital Management, L.P.0
0.000%
-1,262,193decrease
(Position Closed)
Filing
History
2022-09-08
4:00 pm
Purchase
2022-08-3113GAstria Therapeutics, Inc.
ATXS
Vivo Opportunity LLC1,000,000
7.100%
1,000,000increase
(New Position)
Filing
History
2022-09-02
4:10 pm
Purchase
2022-08-2313GAstria Therapeutics, Inc.
ATXS
Cormorant Asset Management, LP1,200,000
5.380%
1,200,000increase
(New Position)
Filing
History
2022-02-24
5:23 pm
Purchase
2021-12-3113GAstria Therapeutics, Inc.
ATXS
BlackRock Inc.
BLK
53,073
0.400%
53,073increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2, 3, Next